Post-discharge medication reviews for patients with heart failure: a pilot study
- 419 Downloads
Background Medication misadventure is greatest at times of change such as the transition from hospital to community. Patients with heart failure are prone to medication misadventure due to polypharmacy, inappropriate medication use and frequent readmissions. Objective To identify the barriers encountered when implementing a Liaison Pharmacist facilitated post-discharge medication management service for patients with heart failure. Method A Liaison Pharmacist contacted the patient’s General Practitioner (GP), sent them a medication discharge summary and organised an appointment for the patient with the GP approximately 2 days post-discharge to make a Home Medicines Review (HMR) referral. The patient’s community pharmacist was also contacted, sent a medication discharge summary and requested to engage an accredited pharmacist to undertake the HMR. The Liaison Pharmacist arranged for the HMR report to be sent to the outpatient department clinic to enable assessment of outcomes at the outpatient department follow-up 12 weeks post-discharge. Main outcome measure: GP HMR referral rates. Results 90 patients were offered the service. Fifty-nine patients (66%) agreed to have their GP contacted with 56 GPs agreeing to order a HMR and 41 patients having an HMR post-discharge. Barriers to the implementation of a HMR post-discharge included: patient withdrawal, low GP awareness of the HMR process and conducting the HMR in a timely manner. Conclusion This study provides evidence for the feasibility of a post-discharge pharmacy service for patients with heart failure although barriers to implementation have been identified.
KeywordsAustralia Care transition Continuity of care Heart failure Liaison pharmacist Medication management Medication review Seamless care
The assistance provided throughout the project by Ms. Olimpia Nigro, Senior Clinical Pharmacist, Royal Adelaide Hospital, is acknowledged with gratitude.
This study was supported by the Sansom Institute, University of South Australia and the Royal Adelaide Hospital.
Conflict of interest
- 2.Bennett A, Brien J. Community liaison pharmacist role in the multi-disciplinary care of heart failure patients. Aust J Pharm. 2002;83:740–3.Google Scholar
- 5.Bennett A, Krass I, Brien J. The future burden of cardiovascular disease: what can pharmacists do? Aust J Pharm. 2005;86:166–9.Google Scholar
- 7.Bennett A, Brien J. Community liaison pharmacist role in the multi-disciplinary care of heart failure patients. Aust J Pharm. 2002;83:740–3.Google Scholar
- 8.Australian Pharmaceutical Advisory Council. National guidelines to achieve the continuum of quality use of medicines between hospital and community. Canberra: Australian Pharmaceutical Advisory Council, Commonwealth Department of Health and Aged Care; 1998.Google Scholar
- 9.Australian Pharmaceutical Advisory Council. Guiding principles to achieve continuity in medication management. Canberra: Australian Pharmaceutical Advisory Council, Commonwealth Department of Health and Aged Care; 2005.Google Scholar
- 11.Australian Council for Safety and Quality in Health Care. Second national report on patient safety: improving medication safety, (Roughead L and Semple S). Canberra: Australian Council for Safety and Quality in Health Care; 2002.Google Scholar
- 14.Stowasser DA, McGuire TM, Petrie GM, Lauchlan RL, Collins D. Information quality: a major consideration in the development of medication liaison services. Aust J Hosp Pharm. 1997;27:362–6.Google Scholar
- 15.McGuire TM. A pharmaceutical care liaison model. Aust J Hosp Pharm. 1996;26:36–7.Google Scholar
- 19.Jaeschke D, Close A, Edwards S, Pecanek H. HMR online resource kit. Pharmacy Guild of Australia and Divisions of General Practice Limited. 2004. http://mail.andgp.org.au/hmr/. Viewed 18 May 2006
- 20.Roughead L, Semple S, Vitry A. The value of pharmacist professional services in the community setting: a systematic review of the literature 1990–2002. University of South Australia; 2003.Google Scholar
- 22.Holland R, Lenaghan E, Ashton K, Hay L, Smith R, Shepstone L, et al. Effectiveness of visits from community pharmacists for patients with heart failure: Heart Med randomised controlled trial. BMJ (online). 2007. doi: 10.1136/bmj.39164.568183.AE.
- 23.Yu K, Nguyen A, Shakib S, Doecke C, Boyce M, March G, et al. Enhancing continuity of care: development of a post-discharge home medicines review model. J Pharm Pract Res. 2007;37(1):22–6.Google Scholar
- 24.Royal Adelaide Hospital. Royal Adelaide Hospital. Adelaide. 2006. <http://www.rah.sa.gov.au/homepage.php>. Viewed 10 October 2006.
- 29.Emerson L. HMRs—the next five years? Pharm Rev. 2005;29(2):36–9.Google Scholar
- 30.Grimmer K, Hedges G, Moss J. Staff perceptions of discharge planning: a challenge for quality improvement. Aust Health Rev. 1999;22(3):95–109.Google Scholar
- 31.Seston EM, Tully MP, Cantrill J. Barriers to the implementation of pharmacist-run prescription monitoring and review services. Pharm J. 1999;263(7063):12–3.Google Scholar
- 33.Frankyl SE, Breeling JL, Goldman L. Preventability of emergent hospital readmissions. Am J Med. 1991;90:667–74.Google Scholar
- 34.Gowan J, Roller L. Chronic disease self management and home medicines reviews. Aust J Pharm. 2004;85:131–3.Google Scholar